Agilent Technologies LSCA - Our measure is your success
clear
white
clear
white
clear

400-DS Apparatus 7 

white
400-DS Apparatus 7 
Integrated features within a small footprint 
The Agilent 400-DS Dissolution Apparatus for small volume sets the performance standard for drug-release testing of medical devices. It is the first dissolution apparatus built specifically for small-volume dissolution testing of combination drug products that meets all compendial requirements for USP Apparatus 7. The 400-DS complies with 21 CFR Part 11 guidelines and brings an unprecedented level of convenience, throughput, and efficiency to your quality control and R&D operations.
Buy
 


Related Information

Features
  • Small-Volume Dissolution Testing. The 400-DS can perform automated dissolution testing using as little as 3 mL media volume in either 5 or 10 mL vessels
  • Bathless Design eliminates sample losses while providing direct and efficient heating
  • Integrated and Efficient Autosampling directly into HPLC vials up to 36 time points. Conveniently removable trays make transportation to the HPLC easy
  • Unique Dissolution Cell Design. Each unit of the 400-DS is capable of testing up to 13 samples in the dissolution cells
  • Reciprocating Holders. Agilent’s patent-pending magnetically-driven reciprocation mechanism is capable of providing dip rates between 5 and 35 DPM, controlled through the software
  • Automated Media Replacement and liquid handling capabilities
  • Low Evaporation Rates. Completely sealed dissolution vessel
  • Software. 21 CFR Part 11 compliant software and a single PC can independently control up to four 400-DS systems

Announcements

Dissolution Source Book 2011-2012

clear
grey2
Please select your country:
 
   
Registration   |  Login Benefits of Registration